RFK, Jr. and four advisers earned at least $3.2 million in fees and salaries from their work opposing Big Pharma and promoting wellness in 2022 and 2023. Here's what to know.
Lightly coating the chicken with a cornstarch mixture is a technique from Chinese cooking that yields juicy, tender pieces. This do-it-all chicken is perfect for dinner, a salad, a sandwich...or even a picnic!
A super-smooth chilled soup bursting with fresh produce is oh-so-refreshing in the summer heat. Any in-season vegetables that you enjoy raw make attractive (but optional) garnishes; I’ve used cherry tomatoes, cucumbers, and chives.
In-season juicy, fragrant honey mangos (AKA Champagne or Ataulfo mangos) are my favorites. Can’t find them? Use any ripe fresh mango or frozen mango that’s thawed to room temperature.
With new limits on food assistance, work requirements for SNAP and Medicaid, as well as substantial cuts to Medicaid itself, millions of Americans will suffer due to this bill. Here's what to know.
A regular update on emerging federal vaccine issues. On July 10, 2025, this list—drawn from news reports and other information—ranks the most significant changes to vaccination policy, with brief commentary from the editors.
VaccinesPeter Lurie, MD, MPH, Sarah Despres, Josh Rising, MD, MPH, Joshua M. Sharfstein, MD
In recent months, we’ve witnessed an assault on science and longstanding safeguards to protect the public’s health on a scale never seen in U.S. history.
On June 26, 2025, the U.S. Supreme Court handed down a 6-3 ruling that preserves free preventive care under the Affordable Care Act, a popular benefit that helps approximately 150 million Americans stay healthy. The case, Kennedy v. Braidwood, was the fourth major legal challenge to the ACA.
In January 2025, CSPI submitted this comment to FDA urging the agency to hold industry accountable for reducing sodium across the food supply. We specifically provided suggestions for improvement on FDA's draft guidance for industry on Phase II voluntary sodium reduction targets for commercially processed, packaged, and prepared foods. We asserted that FDA action to spur industry-side sodium reduction is crucial for Americans' health and that we generally supported the agency's efforts. We also noted that contrary to FDA's preliminary assessment of the effectiveness of its Phase I sodium targets, a CSPI reanalysis did not provide evidence of encouraging industry progress. Lessons from other sodium reduction initiatives show that FDA must be more aggressive with its sodium reduction efforts. Suggested actions included stricter targets, rigorous evaluation, and the consideration of mandatory targets if industry fails to meet voluntary targets.